Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Controversial issues

Digestive Diseases

Volumn 25, Issue 3, 2007, Pages 245-248

  Barbara, Giovanni ^a,b   Stanghellini, Vincenzo ^a   Cremon, Cesare ^a   De Giorgio, Roberto ^a   Corinaldesi, Roberto ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Acute infectious gastroenteritis; Intestinal microflora, role; Irritable bowel syndrome; Irritable bowel syndrome, clinical management; Post infectious irritable bowel syndrome

Indexed keywords

PROBIOTIC AGENT;

ACUTE GASTROENTERITIS; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CONFERENCE PAPER; HUMAN; INFECTION RISK; IRRITABLE COLON; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; THERAPY EFFECT; TREATMENT RESPONSE; ARTICLE; GASTROENTERITIS; INTESTINE; MICROBIOLOGY;

GASTROENTERITIS; HUMANS; INTESTINES; IRRITABLE BOWEL SYNDROME; RISK FACTORS;

EID: 35448970220     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103894     Document Type: Conference Paper

References (20)

1. Chaudhary NA, Truelove SC: The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases. Q J Med 1962;31:307-322.
2. Longstreth GF, Hawkey CJ, Mayer EA, Jones RH, Naesdal J, Wilson IK, Peacock RA, Wiklund IK: Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials. Aliment Pharmacol Ther 2001;15:959-964.
3. Wang LH, Fang XC, Pan GZ: Bacillary dysentery as a causative factor of irritable bowel syndrome and its pathogenesis. Gut 2004;53:1096-1101.
4. Ji S, Park H, Lee D, Song YK, Choi JP, Lee SI: Post-infectious irritable bowel syndrome in patients with Shigella infection. J Gastroenterol Hepatol 2005;20:381-386.
5. Collins SM, Barbara G: East meets West: infection, nerves, and mast cells in the irritable bowel syndrome. Gut 2004;53:1068-1069.
6. Anand AC, Reddy PS, Saiprasad GS, Kher SK: Does non-dysenteric intestinal amoebiasis exist? Lancet 1997;349:89-92.
7. Nanda R, Baveja U, Anand BS: Entamoeba histolytica cyst passers: clinical features and outcome in untreated subjects. Lancet 1984;2:301-303.
8. Sinha P, Ghoshal UC, Choudhuri G, Naik S, Ayyagari A, Naik SR: Does Entamoeba histolytica cause irritable bowel syndrome? Indian J Gastroenterol 1997;16:130-133.
9. Gwee KA: Irritable bowel syndrome in developing countries - a disorder of civilization or colonization? Neurogastroenterol Motil 2005;17:317-324.
10. Spiller RC: Postinfectious irritable bowel syndrome. Gastroenterology 2003;124:1662-1671.
11. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Salvioli B, Corinaldesi R: New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20(suppl 2):1-9.
12. Neal KR, Hebden J, Spiller R: Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997;314:779-782.
13. Barbara G, Stanghellini V, Berti-Ceroni C, De Giorgio R, Salvioli B, Corradi F, Cremon C, Corinaldesi R: Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection. Aliment Pharmacol Ther 2000;14:1127-1131.
14. Isgar B, Harman M, Kaye MD, Whorwell PJ: Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983;24:190-192.
15. Fine KD, Meyer RL, Lee EL: The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology 1997;112:1830-1838.
16. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R: Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005;100:2560-2568.
17. Niaz SK, Sandrasegaran K, Renny FH, Jones BJ: Postinfective diarrhoea and bile acid malabsorption. J R Coll Physicians Lond 1997;31:53-56.
18. Dunlop SP, Jenkins D, Neal KR, Naesdal J, Borgaonker M, Collins SM, Spiller RC: Randomized, double-blind, placebo-controlled trial of prednisolone in post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2003;18:77-84.
19. Pimentel M, Park S, Mirocha J, Kane SV, Kong Y: The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 2006;145:557-563.
20. Neal KR, Barker L, Spiller RC: Prognosis in post-infective irritable bowel syndrome: a six-year follow-up study. Gut 2002;51:410-413.